share_log

华润三九(000999.SZ):目前暂未考虑天士力非中药业务剥离安排

China Resources Sanjiu Medical & Pharmaceutical (000999.SZ): Currently, there is no plan to divest Tasly Pharmaceutical Group's non-traditional chinese medicine business.

Gelonghui Finance ·  Aug 8 03:21

China Resources Sanjiu Medical & Pharmaceutical stated in an investor relations event on August 8 that Tasly Pharmaceutical Group's pipeline of traditional Chinese medicine as the core, with biological and chemical medicine as the auxiliary, is complementary to the business layout of modern traditional Chinese medicine. As we expand the modern traditional Chinese medicine business, we will also specialize in biological and chemical medicine, forming a pipeline complementary business layout. We recognize the pipeline layout of Tasly Pharmaceutical Group and will mutually empower each other in the future to promote the stable leading position of Tasly Pharmaceutical Group in innovative research and development of traditional Chinese medicine. Currently, there is no plan to divest non-traditional Chinese medicine business of Tasly Pharmaceutical Group.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment